Cargando…

Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report

Afatinib has improved the prognosis of epidermal growth factor receptor-positive advanced non-small cell lung cancer and has been explored in the treatment of human epidermal growth factor receptor 2 (HER2)-amplified breast cancer. However, its clinical efficacy in HER2-amplified endometrial cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Li, Ren, Yifeng, Wang, Xia, Miao, Dongliu, Lizaso, Analyn, Li, Haiyan, Han-Zhang, Han, Qian, Jun, Yang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615020/ https://www.ncbi.nlm.nih.gov/pubmed/31308701 http://dx.doi.org/10.2147/OTT.S206732

Ejemplares similares

The efficacy of afatinib in patients with HER2 mutant non-small cell lung cancer: a meta-analysis
por: Zhou, Niya, et al.
Publicado: (2020)

Rechallenge with erlotinib in osimertinib-resistant lung adenocarcinoma mediated by driver gene loss: a case report
por: Liu, Lingli, et al.
Publicado: (2020)

Endometrioid Adenocarcinoma of Caecum Causing Intussusception
por: Verma, Rashmi, et al.
Publicado: (2013)

Efficacy of afatinib in a patient with rare EGFR (G724S/R776H) mutations and amplification in lung adenocarcinoma: A case report
por: He, Shu-Yan, et al.
Publicado: (2021)

An analysis of HER2 amplification in cervical adenocarcinoma: correlation with clinical outcomes and the International Endocervical Adenocarcinoma Criteria and Classification
por: Shi, Haiyan, et al.
Publicado: (2020)

Endometrioid adenocarcinoma arising from adenomyosis: two case reports and a literature review
por: Yang, Jiaying, et al.
Publicado: (2023)

MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
por: Li, Hai Ming, et al.
Publicado: (2015)

Significance of HER2 protein expression and HER2 gene amplification in colorectal adenocarcinomas
por: Wang, Xin-Yu, et al.
Publicado: (2019)

Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER‐targeted therapy in HER2 amplification‐positive and HER2 mutation‐positive amplification‐negative patients
por: Liu, Binliang, et al.
Publicado: (2022)

Efficacy and safety of afatinib in a Chinese population with advanced lung adenocarcinoma with sensitive EGFR mutations
por: Wang, Shouzheng, et al.
Publicado: (2019)

Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients
por: Xiong, Liwen, et al.
Publicado: (2019)

A case of small intestinal endometrioid adenocarcinoma
por: Ogi, Yusuke, et al.
Publicado: (2016)

Endometrioid adenocarcinoma arising from colon endometriosis
por: Palla, Viktoria-Varvara, et al.
Publicado: (2017)

Identification of Distinct Molecular Subtypes of Endometrioid Adenocarcinoma
por: Lei, Jia, et al.
Publicado: (2021)

HER2 Oncogene Amplification and Immunohistochemical Profiling in Gastric Adenocarcinoma
por: Raj, Nisha, et al.
Publicado: (2018)

CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas
por: NAKAYAMA, KENTARO, et al.
Publicado: (2015)

Targeted sequencing identifies the mutational signature of double primary and metastatic malignancies: a case report
por: Rao, Chuangzhou, et al.
Publicado: (2019)

Afatinib combined with anlotinib in the treatment of lung adenocarcinoma patient with novel HER2 mutation: a case report and review of the literature
por: Xu, Huanhuan, et al.
Publicado: (2021)

Afatinib treatment response in advanced lung adenocarcinomas harboring uncommon mutations
por: Li, Teng, et al.
Publicado: (2021)

Therapeutic strategies for afatinib‐resistant lung cancer harboring HER2 alterations
por: Torigoe, Hidejiro, et al.
Publicado: (2018)

Acquired resistance mechanisms to afatinib in HER2‐amplified gastric cancer cells
por: Yoshioka, Takahiro, et al.
Publicado: (2019)

Endometrioid Adenocarcinoma in Urethrovaginal Septum: A Diagnostic Pitfall
por: Lim, Myong Cheol, et al.
Publicado: (2009)

Dedifferentiated endometrioid adenocarcinoma: An under-recognized but aggressive tumor?()
por: Wu, Emily S., et al.
Publicado: (2013)

A Case of Endometrioid Adenocarcinoma Arising from Adenomyosis
por: Taga, Shigeki, et al.
Publicado: (2014)

Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium
por: Lawrenson, Kate, et al.
Publicado: (2015)

HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma
por: Liu, Zimin, et al.
Publicado: (2021)

Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
por: Liang, Sheng-Kai, et al.
Publicado: (2017)

Endometrioid Adenocarcinoma Arising from Endometriosis of the Uterine Cervix: A Case Report
por: Park, Han Moie, et al.
Publicado: (2009)

Afatinib as first‐line treatment for advanced lung adenocarcinoma patients harboring HER2 mutation: A case report and review of the literature
por: Shi, Yuequan, et al.
Publicado: (2018)

The effect of afatinib in a pretreated patient with invasive mucinous adenocarcinoma of the lung harboring HER2 YVMA insertion: a case report
por: He, Yueming, et al.
Publicado: (2022)

Afatinib-Induced Acute Fatal Pneumonitis in Metastatic Lung Adenocarcinoma
por: Yoo, Sang Hoon, et al.
Publicado: (2016)

Simultaneous Inhibition of EGFR and HER2 via Afatinib Augments the Radiosensitivity of Nasopharyngeal Carcinoma Cells
por: Huang, Fangling, et al.
Publicado: (2019)

Long-term efficacy of afatinib in a patient with squamous cell carcinoma of the lung and multiple ERBB family aberrations: afatinib in ERBB+ lung squamous cell carcinoma
por: Jian, Hong, et al.
Publicado: (2019)

Peritoneal keratin granuloma associated with endometrioid adenocarcinoma of the uterine corpus
por: Uehara, Keiichiro, et al.
Publicado: (2011)

Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium?
por: Bassarak, Nina, et al.
Publicado: (2010)

Circulating microRNAs as a Fingerprint for Endometrial Endometrioid Adenocarcinoma
por: Wang, Lin, et al.
Publicado: (2014)

An Unusual Solitary Metatarsal Metastasis from an Endometrioid Endometrial Adenocarcinoma
por: Longo, Raffaele, et al.
Publicado: (2015)

Dedifferentiated endometrioid adenocarcinoma; clinicopathologic and immunohistochemical features of five cases
por: Yiğit, Seyran, et al.
Publicado: (2018)

Ovarian Carcinoid Misinterpreted as Endometrioid Adenocarcinoma in Mature Cystic Teratoma
por: Tewari, Prerna, et al.
Publicado: (2020)

RelB/NF-κB links cell cycle transition and apoptosis to endometrioid adenocarcinoma tumorigenesis
por: Ge, Qiu-Lin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_196211ra2prdnd38ln92bapk3a